Phase I study of CC-486 alone and in combination with carboplatin or nab-paclitaxel in patients with relapsed or refractory solid tumors

  1. Von Hoff, D.D.
  2. Rasco, D.W.
  3. Heath, E.I.
  4. Munster, P.N.
  5. Schellens, J.H.M.
  6. Isambert, N.
  7. Le Tourneau, C.
  8. O'Neil, B.
  9. Mathijssen, R.H.J.
  10. Lopez-Martin, J.A.
  11. Jeff Edenfield, W.
  12. Martin, M.
  13. LoRusso, P.M.
  14. Bray, G.L.
  15. DiMartino, J.
  16. Nguyen, A.
  17. Liu, K.
  18. Laille, E.
  19. Bendell, J.C.
Journal:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Year of publication: 2018

Volume: 24

Issue: 17

Pages: 4072-4080

Type: Article

DOI: 10.1158/1078-0432.CCR-17-3716 GOOGLE SCHOLAR lock_openOpen access editor